Saraireh HA, Bilal M, Singh S. Role of endoscopic ultrasound in liver disease: Where do we stand in 2017? World J Hepatol 2017; 9(24): 1013-1021 [PMID: 28932347 DOI: 10.4254/wjh.v9.i24.1013]
Corresponding Author of This Article
Shailendra Singh, MD, Division of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, United States. shail121@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Aug 28, 2017; 9(24): 1013-1021 Published online Aug 28, 2017. doi: 10.4254/wjh.v9.i24.1013
Role of endoscopic ultrasound in liver disease: Where do we stand in 2017?
Hamzeh A Saraireh, Mohammad Bilal, Shailendra Singh
Hamzeh A Saraireh, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States
Mohammad Bilal, Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, TX 77555, United States
Shailendra Singh, Division of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, Pittsburgh, PA 15212, United States
Author contributions: Saraireh HA and Bilal M performed literature review and search; Saraireh HA wrote the initial manuscript which was edited by Bilal M; Bilal M wrote certain parts of the manuscript; Singh S was involved in editing the manuscript and provided expert opinion.
Conflict-of-interest statement: The authors report no conflict of interest and have no financial disclosures.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Shailendra Singh, MD, Division of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, United States. shail121@gmail.com
Telephone: +1-412-2775244 Fax: +1-412-3598439
Received: April 7, 2017 Peer-review started: April 10, 2017 First decision: May 19, 2017 Revised: June 11, 2017 Accepted: July 21, 2017 Article in press: July 24, 2017 Published online: August 28, 2017
Abstract
Endoscopic ultrasound (EUS) was first introduced into medical practice in 1980s as a diagnostic imaging modality for pancreatic pathology. EUS has the unique advantage of combining ultrasound and endoscopy to obtain detailed information of the gastrointestinal tract. Over the past decade, the use of EUS in liver diseases has been increasing. EUS, which was initially used as a diagnostic tool, is now having increasing therapeutic role as well. We provide a review of the application of EUS in the diagnostic and therapeutic aspects of liver disease. We also look at the evolving future research on the role of EUS in liver diseases.
Core tip: We have summarized the up-to-date literature on the emerging role of endoscopic ultrasound (EUS) in liver disease. This brief review summarizes both the diagnostic and therapeutic role of EUS in focal hepatic lesions, portal hypertension, liver abscess and hepatic cysts. We have also summarized the future research on this subject.
